- Report
- July 2024
- 185 Pages
Global
From €4017EUR$4,500USD£3,493GBP
- Report
- September 2024
- 158 Pages
Global
From €2232EUR$2,500USD£1,940GBP
- Report
- January 2021
- 201 Pages
Global
From €3214EUR$3,600USD£2,794GBP
- Report
- October 2025
- 150 Pages
Germany
From €3437EUR$3,850USD£2,988GBP
- Report
- September 2025
- 150 Pages
China
From €3437EUR$3,850USD£2,988GBP
- Report
- September 2025
- 150 Pages
Canada
From €3437EUR$3,850USD£2,988GBP
- Report
- August 2024
- 110 Pages
Global
From €3526EUR$3,950USD£3,066GBP
- Report
- May 2024
- 130 Pages
Global
From €3526EUR$3,950USD£3,066GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2490EUR$2,789USD£2,165GBP
- Report
- June 2025
- 250 Pages
Mexico
From €2490EUR$2,789USD£2,165GBP
- Report
- June 2025
- 250 Pages
Vietnam
From €2490EUR$2,789USD£2,165GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2490EUR$2,789USD£2,165GBP
- Report
- June 2025
- 250 Pages
Japan
From €2490EUR$2,789USD£2,165GBP
- Report
- October 2024
- 200 Pages
Global
From €4418EUR$4,949USD£3,841GBP
- Report
- December 2023
- 160 Pages
United States
From €2490EUR$2,789USD£2,165GBP
- Report
- May 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,841GBP
- Report
- April 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,841GBP
- Report
- April 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,841GBP
- Report
- October 2023
- 180 Pages
Global
From €1116EUR$1,250USD£970GBP
€2232EUR$2,500USD£1,940GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1339EUR$1,500USD£1,164GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more